Singleplex Immunoassay Market Research Report – Forecast to 2027

Global Singleplex Immunoassay Market Research Report: By Products and Services (Consumables, Others), by Type (Protein-Based Assays, Nucleic Acid Based Assays, Others), Technology (Flow Cytometry, Others), Application, End-User - Global Forecast Till 2027

ID: MRFR/LS/4737-HCR | February 2021 | Region: Global | 100 pages

Please note that the assessment period of report has been updated from 2018–2023 to 2020-2027. Cordially fill the sample form for updated data.

Market Scenario
The global singleplex immunoassay market is expected to gain prominence over the forecast period (2018–2023). It is estimated that the global singleplex immunoassay market is expected to register a CAGR ~ 8.4 % during the forecast period of 2018–2023.
Singleplex immunoassays such as Enzyme-Linked Immunosorbent Assays (ELISA) or western blotting are used sequentially to analyze multiple intracellular and extracellular proteins. Moreover, singleplex immunoassay provides a fast and high-through output solution for gene expression quantification. For instance, Thermo Fisher Scientific’s QuantiGene Singleplex assay is developed to detect original RNA or DNA population using signal amplification.
Numerous factors such as growth in the biotechnology and pharmaceutical sector, increasing adoption of rental immunoassay analyzers, and rising use of immunoassay in oncology fuels the growth of global singleplex immunoassay. Additionally, that rising prevalence of chronic diseases will push the demand for singleplex immunoassay technologies.
Moreover, the growing awareness about immunoassay, enhanced focus on diagnostic testing, and increasing government assistance are continuously contributing to the growth of the global singleplex immunoassay market.
Despite the drivers, some factors such as the stringent FDA regulations, the emergence of multiplex immunoassays, the complex procedure of testing, and poor healthcare system in low and middle-income countries may hamper the growth of the market to an extent.
Company Profiles    
  • Luminex
  • Thermo Fisher Scientific
  • Illumina
  • Bio-Rad Laboratories
  • QIAGEN N.V
  • Abcam
  • Becton Dickinson and Company
  • Merck Life sciences
  • Agilent Technologies
  • Quanterix
  • Bio-Techne
  • Olink
  • Seegene
  • BioVendor
  • Others

Segmentation

The global singleplex immunoassay market is segmented on the basis of the product and service, type, technology, application, and end-user.

On the basis of the product and services, the market is classified as consumables, instruments, and others.

The global singleplex immunoassay market on the basis of the type is segmented as protein-based assays, nucleic acid-based assays, cell-based assays, and others.

On the basis of technology, the market is segmented into flow cytometry, fluorescence detection, and others.

The global singleplex immunoassay market, by application, is segmented into research and development, clinical diagnostics, and others. The research and development are further segmented into drug discovery & development and biomarker discovery and validation. The clinical diagnostics are further segmented into infectious diseases, cancer, cardiovascular diseases, autoimmune diseases, nervous system disorders, and metabolism & endocrinology disorders.

On the basis of the end-user, the global singleplex immunoassay market is segmented as pharmaceutical & biotechnology companies, hospitals & research institutes, reference laboratories and others.

Geographically, global singleplex immunoassay market has been segmented into America, Europe, Asia-Pacific, and the Middle East & Africa. The Americas singleplex immunoassay market is further segmented into North America, and South America. North America is further classified as the US and Canada.

The Europe singleplex immunoassay market is segmented into Western Europe and Eastern Europe. Western Europe is further classified as Germany, France, the UKUK, Italy, Spain, and the Rest of Western Europe.

The Asia-Pacific singleplex immunoassay market is segmented into Japan, China, India, Republic of Korea, Australia, and Rest of Asia-Pacific.

The Middle East & Africa singleplex immunoassay market is segmented into the Middle East, and Africa.

Regional Market Summary

Global Singleplex Immunoassay Market, by Region Market Share, 2017 (%)

 Singleplex Immunoassay Market

Source: MRFR Analysis

The global singleplex immunoassay market consists of four regions: Americas, Europe, Asia-Pacific and the Middle East & Africa. The Americas is expected to dominate the singleplex immunoassay market owing to the presence of major market players, high adoption rate, and increasing prevalence of infectious diseases. According to the statistics suggested by the Centers for Disease Control (CDC) and Prevention, in 2014,  around 9,421 cases of tuberculosis, 51,455 cases of salmonella, 33,461 cases of Lyme disease, and 433 cases of meningococcal disease were registered in the United States.

Europe is anticipated to hold the second position in the global singleplex immunoassay market. It is expected that the rising automation in an immunoassay, increasing prevalence of chronic diseases, funding provided by the government, and private organizations towards research & development are anticipated to drive the European market.

The Asia-Pacific singleplex immunoassay market consists of countries namely China, Japan, Republic of Korea, India, Australia and Rest of Asia-Pacific. Asia-Pacific is the fastest growing in singleplex immunoassay market. Major factors such as growing patient pool, high incidence of chronic diseases, developing healthcare infrastructure and increasing research & development activities in the biotechnology sector, increasing healthcare expenditure influences the market in this region. Additionally, according to the data suggested by the Australian Institute of Health and Welfare during the year 2015-16, the total health expenditure was USD 170.4 billion, i.e., 3.6 % higher than the expenditure of 2014-2015.

The Middle East and Africa hold the least share in the global singleplex immunoassay market due to the presence of stringent government policies and poor economies. However, growing awareness among the population and high investments by private market players in this region can boost the market growth.


Research Methodology

Market Research Future research is conducted by industry experts who offer insight into industry structure, market segmentation, Treatment assessment, competitive landscape (CL), penetration, as well as on emerging trends. Besides primary interviews (~ 80%) and secondary research (~ 20%), their analysis is based on their years of professional expertise in respective industries. Our analysts also predict where the market will be headed in the next five to ten years, by analyzing historical trends and current market positions. Furthermore, the varying trends of segments & categories geographically presented are studied and are estimated based on primary & secondary research.

  • Primary Research

The extensive primary research was conducted to gain a deeper insight into the market and the industry performance. In this particular report, we have conducted primary surveys (interviews) with the key level executives (VPs, CEOs, Marketing Directors, Business Development Managers, and many more) of the major players who are active in the market. In addition to analyzing the current and historical trends, our analysts predict where the market is headed, over the next five to ten years.

  • Secondary Research

Secondary research was mainly used to collect and identify information useful for an extensive, technical, market-oriented, and commercial study of the global singleplex immunoassay market. It was also used to obtain key information about major players, market classification and segmentation according to the industry trends, geographical markets, & developments related to the market and Treatment Perspectives. For this study, analysts have gathered information from various credible sources, such as annual reports, SEC filings, journals, white papers, corporate presentations, company websites, the international organization of chemical manufacturers, some paid databases and many others.

Global Singleplex Immunoassay Market, by Product and Service

  • Consumables
  • Instruments
  • Others

Global Singleplex Immunoassay Market, by Type

  • Protein-Based Assays
  • Nucleic Acid Based Assays
  • Cell-Based Assays
  • Others

Global Singleplex Immunoassay Market, by Technology

  • Flow Cytometry
  • Fluorescence Detection

Global Singleplex Immunoassay Market, by Application

  • Research & Development
  • Drug Discovery & Development
  • Biomarker Discovery & Validation
  • Clinical Diagnostics
  • Infectious Diseases
  • Cancer
  • Cardiovascular Diseases
  • Autoimmune Diseases
  • Nervous System Disorders
  • Metabolism & Endocrinology Disorders
  • Others

Global Singleplex Immunoassay Market, by End-user

  • Pharmaceutical & Biotechnology Companies
  • Hospitals & Research Institutes
  • Reference Laboratories
  • Others

Global Singleplex Immunoassay Market, by Region

  • Americas
  • North America
  • US
  • Canada
  • South America
  • Europe
  • Western Europe
  • Germany
  • France
  • Italy
  • Spain
  • UK
  • Rest of Western Europe
  • Eastern Europe
  • Asia-Pacific
  • Japan
  • China
  • India
  • Australia
  • Republic of Korea
  • Rest of Asia-Pacific
  • The Middle East & Africa
  • Middle East
  • Africa

Intended Audience

  • Pharmaceutical Companies
  • Medical Device Companies
  • Research and Development (R&D) Companies
  • Diagnostic Laboratories
  • Government Research Institute
  • Academic Institutes and Universities



Report Scope:
Report Attribute/Metric Details
  Market Size   Significant Value
  CAGR   2018-2023: ~8.4%
  Base Year   2019
  Forecast Period   2027
  Historical Data   2018
  Forecast Units   Value (USD Million)
  Report Coverage   Revenue Forecast, Competitive Landscape, Growth Factors, and Trends
  Segments Covered   Product And Service, Type, Technology, Application, And End-User
  Geographies Covered   North America, Europe, Asia-Pacific, and Rest of the World (RoW)
  Key Vendors   Luminex, Thermo Fisher Scientific, Illumina, Bio-Rad Laboratories, QIAGEN N.V, Abcam, Becton Dickinson and Company, Merck Life sciences, Agilent Technologies, Quanterix, Bio-Techne, Olink, Seegene, BioVendor
  Key Market Opportunities   Government assistance
  Key Market Drivers   Rising prevalence of chronic diseases and growing biotechnology sector


Frequently Asked Questions (FAQ) :


Singleplex Immunoassay Market is projected to grow at an 8.4% CAGR between 2018-2023.

The Americas is expected to lead the Singleplex Immunoassay Market.

Rising prevalence of chronic diseases and growing biotechnology sector is boosting market growth.

Poor healthcare system may limit market growth.

Different strategies used by market players to create a dominance in the Singleplex Immunoassay Market growth include mergers, collaborations, product developments, and R&D.

Table of Contents: Chapter 1. Report Prologue Chapter 2. Market Introduction 2.1 Definition 2.2 Scope of the Study 2.2.1 Research Objective 2.2.2 Assumptions 2.2.3 Limitations Chapter 3. Research Methodology3.1 Introduction3.2 Primary Research 3.3 Secondary Research 3.4 Market Size EstimationChapter 4. Market Dynamics4.1 Drivers 4.2 Restraints4.3 Opportunities 4.4 Challenges4.5 Macroeconomic Indicators4.6 Technology Trends & AssessmentChapter 5. Market Factor Analysis5.1 Porter’s Five Forces Analysis5.1.1 Bargaining Power of Suppliers 5.1.2 Bargaining Power of Buyers5.1.3 Threat of New Entrants 5.1.4 Threat of Substitutes 5.1.5 Intensity of Rivalry 5.2 Value Chain Analysis5.3 Investment Feasibility Analysis 5.4 Pricing AnalysisChapter 6. Global Singleplex Immunoassay Market, by Product and Service6.1 Introduction6.2 ConsumablesMarket Estimates & Forecast, by Region, 2020-2027Market Estimates & Forecast, by Country, 2020-20276.3 InstrumentsMarket Estimates & Forecast, by Region, 2020-2027Market Estimates & Forecast, by Country, 2020-20276.4 OthersMarket Estimates & Forecast, by Region, 2020-2027Market Estimates & Forecast, by Country, 2020-2027Chapter 7. Global Singleplex Immunoassay Market, by Type7.1 Introduction7.2 Protein-Based AssaysMarket Estimates & Forecast, by Region, 2020-2027Market Estimates & Forecast, by Country, 2020-20277.3 Nucleic Acid Based AssaysMarket Estimates & Forecast, by Region, 2020-2027Market Estimates & Forecast, by Country, 2020-20277.4 Cell-Based AssaysMarket Estimates & Forecast, by Region, 2020-2027Market Estimates & Forecast, by Country, 2020-20277.5 OthersMarket Estimates & Forecast, by Region, 2020-2027Market Estimates & Forecast, by Country, 2020-2027Chapter 8. Global Singleplex Immunoassay Market, by Technology8.1 Introduction8.2 Flow CytometryMarket Estimates & Forecast, by Region, 2020-2027Market Estimates & Forecast, by Country, 2020-20278.3 Fluorescence DetectionMarket Estimates & Forecast, by Region, 2020-2027Market Estimates & Forecast, by Country, 2020-20278.4 OthersMarket Estimates & Forecast, by Region, 2020-2027Market Estimates & Forecast, by Country, 2020-2027Chapter 9. Global Singleplex Immunoassay Market, by Application9.1 Introduction9.2 Research & Development9.2.1 Drug Discovery & DevelopmentMarket Estimates & Forecast, by Region, 2020-2027Market Estimates & Forecast, by Country, 2020-20279.2.2 Biomarker Discovery & validationMarket Estimates & Forecast, by Region, 2020-2027Market Estimates & Forecast, by Country, 2020-20279.3 Clinical Diagnostics9.3.1 Infectious DiseasesMarket Estimates & Forecast, by Region, 2020-2027Market Estimates & Forecast, by Country, 2020-20279.3.2 CancerMarket Estimates & Forecast, by Region, 2020-2027Market Estimates & Forecast, by Country, 2020-20279.3.3 Cardiovascular DiseasesMarket Estimates & Forecast, by Region, 2020-2027Market Estimates & Forecast, by Country, 2020-20279.3.4 Autoimmune DiseasesMarket Estimates & Forecast, by Region, 2020-2027Market Estimates & Forecast, by Country, 2020-20279.3.5 Nervous System DisordersMarket Estimates & Forecast, by Region, 2020-2027Market Estimates & Forecast, by Country, 2020-20279.3.6 Metabolism & Endocrinology DisordersMarket Estimates & Forecast, by Region, 2020-2027Market Estimates & Forecast, by Country, 2020-20279.4 OthersMarket Estimates & Forecast, by Region, 2020-2027Market Estimates & Forecast, by Country, 2020-2027Chapter 10. Global Singleplex Immunoassay Market, by End-User10.1 Introduction10.2 Pharmaceuticals & Biotechnology CompaniesMarket Estimates & Forecast, by Region, 2020-2027Market Estimates & Forecast, by Country, 2020-202710.3 Hospital & Research InstitutesMarket Estimates & Forecast, by Region, 2020-2027Market Estimates & Forecast, by Country, 2020-202710.4 Reference LaboratoriesMarket Estimates & Forecast, by Region, 2020-2027Market Estimates & Forecast, by Country, 2020-202710.5 OthersMarket Estimates & Forecast, by Region, 2020-2027Market Estimates & Forecast, by Country, 2020-2027Chapter 11. Global Singleplex Immunoassay Market, by Region11.1 Introduction11.2 Americas11.2.1 North America11.2.1.1 US11.2.1.2 Canada11.2.2 South America11.3 Europe11.3.1 Western Europe11.3.1.1 Germany11.3.1.2 France11.3.1.3 Italy11.3.1.4 Spain11.3.1.5 UK11.3.1.6 Rest of Western Europe11.3.2 Eastern Europe11.4 Asia Pacific11.4.1 Japan11.4.2 China11.4.3 India11.4.4 Australia11.4.5 Republic of Korea11.4.6 Rest of Asia Pacific11.5 The Middle East & Africa11.5.1 The Middle East11.5.2 AfricaChapter 12. Company Landscape 12.1 Introduction 12.2 Market Share Analysis 12.3 Key Development & Strategies Chapter 13. Company Profiles 13.1 Luminex13.1.1 Company Overview 13.1.2 Product Overview 13.1.3 Financials Overview13.1.4 Key Developments 13.1.5 SWOT Analysis 13.2 Thermo Fisher Scientific13.2.1 Company Overview 13.2.2 Product Overview 13.2.3 Financial Overview 13.2.4 Key Developments 13.2.5 SWOT Analysis 13.3 Illumina13.3.1 Company Overview 13.3.2 Product Overview 13.3.3 Financial Overview13.3.4 Key Development 13.3.5 SWOT Analysis 13.4 Bio-Rad Laboratories13.4.1 Company Overview 13.4.2 Technology/Business Segment Overview 13.4.3 Financial Overview 13.4.4 Key Development 13.4.5 SWOT Analysis 13.5 QIAGEN N. V13.5.1 Company Overview 13.5.2 Product Overview 13.5.3 Financial overview 13.5.4 Key Developments13.5.5 SWOT Analysis 13.6 Abcam13.6.1 Company Overview 13.6.2 Product Overview 13.6.3 Financial Overview 13.6.4 Key Developments13.6.5 SWOT Analysis 13.7 Becton Dickinson and Company13.7.1 Overview 13.7.2 Product Overview 13.7.3 Financial Overview 13.7.4 Key Developments 13.7.5 SWOT Analysis 13.8 Merck Life Sciences13.8.1 Overview 13.8.2 Product/ Technology Overview 13.8.3 Financials 13.8.4 Key Developments 13.8.5 SWOT Analysis13.9 Agilent Technologies13.9.1 Overview 13.9.2 Product Overview 13.9.3 Financials 13.9.4 Key Developments 13.9.5 SWOT Analysis13.10 Quanterix13.10.1 Overview 13.10.2 Product Overview 13.10.3 Financials 13.10.4 Key Developments 13.10.5 SWOT Analysis13.11 Bio-Techne13.11.1 Overview 13.11.2 Product Overview 13.11.3 Financials 13.11.4 Key Developments 13.11.5 SWOT Analysis13.12 Olink13.12.1 Overview 13.12.2 Product Overview 13.12.3 Financials 13.12.4 Key Developments 13.12.5 SWOT Analysis13.13 Seegene13.13.1 Overview 13.13.2 Product Overview 13.13.3 Financials 13.13.4 Key Developments 13.13.5 SWOT Analysis13.14 BioVendor13.14.1 Overview 13.14.2 Product Overview 13.14.3 Financials 13.14.4 Key Developments 13.14.5 SWOT Analysis13.15 OthersChapter 14 MRFR Conclusion 14.1 Key Findings 14.1.1 From CEO’s View Point 14.1.2 Unmet Needs of the Market 14.2 Key Companies to Watch 14.3 Prediction of the Arthroscopy Instruments IndustryChapter 15 AppendixLIST OF TABLESTable 1 Global Singleplex Immunoassay Market Synopsis, 2020-2027Table 2 Global Singleplex Immunoassay Market Estimates and Forecast, 2020-2027, (USD Million)Table 3 Global Singleplex Immunoassay Market, by Region, 2020-2027, (USD Million)Table 4 Global Singleplex Immunoassay Market, by Product and Service, 2020-2027, (USD Million)Table 5 Global Singleplex Immunoassay Market, by Type, 2020-2027, (USD Million)Table 6 Global Singleplex Immunoassay Market, by Technology, 2020-2027, (USD Million)Table 7 Global Singleplex Immunoassay Market, by Application, 2020-2027, (USD Million)Table 8 Global Singleplex Immunoassay Market, by End-User, 2020-2027, (USD Million)Table 9 North America Global Singleplex Immunoassay Market, by Product and Service, 2018–2023, (USD Million)Table 10 North America Global Singleplex Immunoassay Market, by Type, 2020-2027, (USD Million)Table 11 North America Global Singleplex Immunoassay Market, by Technology, 2020-2027, (USD Million)Table 12 North America Global Singleplex Immunoassay Market, by Application, 2020-2027, (USD Million)Table 13 North America Global Singleplex Immunoassay Market, by End-User, 2020-2027, (USD Million) Table 14 US Singleplex Immunoassay Market, by Product and Service, 2020-2027, (USD Million)Table 15 US Singleplex Immunoassay Market, by Type, 2020-2027, (USD Million)Table 16 US Singleplex Immunoassay Market, by Technology, 2020-2027, (USD Million)Table 17 US Singleplex Immunoassay Market, by Application, 2020-2027, (USD Million)Table 18 US Singleplex Immunoassay Market, by End-User, 2020-2027, (USD Million)Table 19 Canada Singleplex Immunoassay Market, by Product and Service, 2020-2027, (USD Million)Table 20 Canada Singleplex Immunoassay Market, by Type, 2020-2027, (USD Million)Table 21 Canada Singleplex Immunoassay Market, by Technology, 2020-2027, (USD Million)Table 22 Canada Singleplex Immunoassay Market, by Application, 2020-2027, (USD Million)Table 23 Canada Singleplex Immunoassay Market, by End-User, 2020-2027, (USD Million)Table 24 South America Singleplex Immunoassay Market, by Product and Service, 2020-2027, (USD Million)Table 25 South America Singleplex Immunoassay Market, by Type, 2020-2027, (USD Million)Table 26 South America Singleplex Immunoassay Market, by Technology, 2020-2027, (USD Million)Table 27 South America Singleplex Immunoassay Market, by Application, 2020-2027, (USD Million)Table 28 South America Singleplex Immunoassay Market, by End-User, 2020-2027, (USD Million)Table 29 Europe Singleplex Immunoassay Market, by Product and Service, 2020-2027, (USD Million)Table 30 Europe Singleplex Immunoassay Market, by Type, 2020-2027, (USD Million)Table 31 Europe Singleplex Immunoassay Market, by Technology, 2020-2027, (USD Million)Table 32 Europe Singleplex Immunoassay Market, by Application, 2020-2027, (USD Million)Table 33 Europe Singleplex Immunoassay Market, by End-User, 2020-2027, (USD Million)Table 34 Western Europe Singleplex Immunoassay Market, by Product and Service, 2020-2027, (USD Million)Table 35 Western Europe Singleplex Immunoassay Market, by Type, 2020-2027, (USD Million)Table 36 Western Europe Singleplex Immunoassay Market, by Technology, 2020-2027, (USD Million)Table 37 Western Europe Singleplex Immunoassay Market, by Application, 2020-2027, (USD Million)Table 38 Western Europe Singleplex Immunoassay Market, by End-User, 2020-2027, (USD Million)Table 39 Eastern Europe Singleplex Immunoassay Market, by Product and Service, 2020-2027, (USD Million)Table 40 Eastern Europe Singleplex Immunoassay Market, by Type, 2020-2027, (USD Million)Table 41 Eastern Europe Singleplex Immunoassay Market, by Technology, 2020-2027, (USD Million)Table 42 Eastern Europe Singleplex Immunoassay Market, by Application, 2020-2027, (USD Million)Table 43 Eastern Europe Singleplex Immunoassay Market, by End-User, 2020-2027, (USD Million)Table 44 Asia Pacific Singleplex Immunoassay Market, by Product and Service, 2020-2027, (USD Million)Table 45 Asia Pacific Singleplex Immunoassay Market, by Type, 2020-2027, (USD Million)Table 46 Asia Pacific Singleplex Immunoassay Market, by Technology, 2020-2027, (USD Million)Table 47 Asia Pacific Singleplex Immunoassay Market, by Application, 2020-2027, (USD Million)Table 48 Asia Pacific Singleplex Immunoassay Market, by End-User, 2020-2027, (USD Million)Table 49 Middle East & Africa Singleplex Immunoassay Market, by Product and Service, 2018–2023, (USD Million)Table 50 Middle East & Africa Singleplex Immunoassay Market, by Type, 2020-2027, (USD Million)Table 51 Middle East & Africa Singleplex Immunoassay Market, by Technology, 2020-2027, (USD Million)Table 52 Middle East & Africa Singleplex Immunoassay Market, by Application, 2020-2027, (USD Million)Table 53 Middle East & Africa Singleplex Immunoassay Market, by End-User, 2020-2027, (USD Million) LIST OF FIGURESFigure 1 Research ProcessFigure 2 Segmentation for Global Singleplex Immunoassay MarketFigure 3 Segmentation Market Dynamics for Global Singleplex Immunoassay MarketFigure 4 Global Singleplex Immunoassay Market Share, by Product and Service 2020Figure 5 Global Singleplex Immunoassay Market Share, by Type 2020Figure 6 Global Singleplex Immunoassay Market Share, by Technology 2020Figure 7 Global Singleplex Immunoassay Market Share, by Application 2020Figure 8 Global Singleplex Immunoassay Market Share, by End-User, 2020Figure 9 Global Singleplex Immunoassay Market Share, by Region, 2020Figure 10 North America Singleplex Immunoassay Market Share, by Country, 2020Figure 11 Europe Singleplex Immunoassay Market Share, by Country, 2020Figure 12 Asia Pacific Singleplex Immunoassay Market Share, by Country, 2020Figure 13 Middle East & Africa Singleplex Immunoassay Market Share, by Country, 2020Figure 14 Global Singleplex Immunoassay Market: Company Share Analysis, 2020 (%)Figure 15 Luminex: Key FinancialsFigure 16 Luminex: Segmental RevenueFigure 17 Luminex: Geographical RevenueFigure 18 Thermo Fisher Scientific: Key FinancialsFigure 19 Thermo Fisher Scientific: Segmental RevenueFigure 20 Thermo Fisher Scientific: Geographical RevenueFigure 21 Illumina::Key FinancialsFigure 22 Illumina: Segmental RevenueFigure 23 Illumina: Geographical RevenueFigure 24 Bio-Rad Laboratories: Key FinancialsFigure 25 Bio-Rad Laboratories: Segmental RevenueFigure 26 Bio-Rad Laboratories: Geographical RevenueFigure 27 QIAGEN N. V:Key FinancialsFigure 28 QIAGEN N. V: Segmental RevenueFigure 29 QIAGEN N. V. Geographical RevenueFigure 30 Abcam: Key FinancialsFigure 31 Abcam: Segmental RevenueFigure 32 Abcam: Geographical RevenueFigure 33 Becton Dickinson and Company: Key FinancialsFigure 34 Becton Dickinson and Company: Segmental RevenueFigure 35 Becton Dickinson and Company: Geographical RevenueFigure 36 Merck Life Sciences: Key FinancialsFigure 37 Merck Life Sciences: Segmental RevenueFigure 38 Merck Life Sciences: Geographical RevenueFigure 39 Agilent Technologies: Key FinancialsFigure 40 Agilent Technologies: Segmental RevenueFigure 41 Agilent Technologies: Geographical Revenue Figure 42 Quanterix: Key FinancialsFigure 43 Quanterix: Segmental RevenueFigure 44 Quanterix: Geographical RevenueFigure 45 Bio-Techne: Key FinancialsFigure 46 Bio-Techne: Segmental RevenueFigure 47 Bio-Techne: Geographical Revenue Figure 48 Olink: Key FinancialsFigure 49 Olink: Segmental RevenueFigure 50 Olink: Geographical RevenueFigure 51 Seegene: Key FinancialsFigure 52 Seegene: Segmental RevenueFigure 53 Seegene: Geographical RevenueFigure 54 BioVendor: Key FinancialsFigure 55 BioVendor: Segmental RevenueFigure 56 BioVendor: Geographical Revenue